Purchase Order 75N91024P00562
Award Date 7/29/24
Potential Completion Date 9/2/24
Potential Value $41K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute (NCI) awarded a $17,501 firm fixed price blanket purchase agreement (BPA) call to Nanostring Technologies, Inc. for nanoString CosMx Spatial Gene Expression Library Preparation Kits. The contract, awarded on April 18, 2024, with an ultimate completion date of April 17, 2025, will be performed at the NCI facility in Bethesda, Maryland. This award carries no set-aside designation and represents a continuation of the government's procurement relationship with...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,741 purchase order to Nanostring Technologies, Inc. of Seattle, Washington for reagents. The firm fixed price contract runs from August 25, 2023 through September 25, 2023 and supports the NIH NCI's research efforts. As a leading provider of life science tools for translational research and molecular diagnostic products, Nanostring will deliver the requested reagents to aid in the...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a firm-fixed-price purchase order to Nanostring Technologies, Inc., a for-profit manufacturer of life science tools, for the provision of NanoString GeoMX Digital Spatial Profiling and nCounter MAX System equipment and services to support the Laboratory of Pathology's Single-Cell RNA Facility. The $496,250 contract has a completion date of September 3, 2020 and does not utilize a...
- The National Cancer Institute awarded Nanostring Technologies, Inc. a $5,974.50 firm fixed price call against a blanket purchase agreement for biological materials, chemicals, and laboratory supplies on April 17, 2018. The contract, which was not set aside for small businesses, represents a delivery order for specialized genomic analysis consumables and reagents to support the National Cancer Institute's research initiatives. The work was completed by May 17, 2018, with performance taking...
- Nanostring Technologies, Inc. was awarded a $25K firm fixed price blanket purchase agreement (BPA) call from the National Cancer Institute (NCI), a component of the National Institutes of Health, with a completion date of October 6, 2017. The award was issued without a set-aside designation and utilized existing BPA terms to procure specialized genomic analysis products or services from the Seattle, Washington-based vendor. This procurement aligns with NCI's mission to support cancer research...
- Nanostring Technologies, Inc. received a federal contract award from the National Cancer Institute (NCI) on April 14, 2016, valued at $13,633.50 under a Blanket Purchase Agreement (BPA) call with a firm fixed price structure. The contract, which was completed by August 31, 2016, was issued without a set-aside designation. The work was performed at Nanostring's Seattle, Washington facility. As a leading provider of advanced genomic analysis platforms, Nanostring supplied specialized laboratory...
- This is a $20,300 firm fixed price contract awarded by the National Cancer Institute (NCI) to Nanostring Technologies, Inc. to provide the NCI with specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and cellular analysis for biomedical research and healthcare programs. The contract is a blanket purchase agreement (BPA) call order that allows the NCI to procure products and services compatible with Nanostring's nCounter Analysis Systems and...
- NanoString Technologies, Inc. received a federal contract award from the National Cancer Institute (NCI) on August 30, 2016, valued at $8,520.00 with a firm fixed price structure. This award was issued as a Blanket Purchase Agreement (BPA) call with an ultimate completion date of September 12, 2016 and was performed in Bethesda, Maryland. No set-aside designation was applied to this contract. NanoString Technologies is a provider of advanced genomic analysis platforms and life science tools,...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $246,650.00 firm-fixed-price purchase order to Nanostring Technologies, Inc. for a GeoMx Digital Spatial Profiler (DSP) analysis instrument. The purpose is to support the Center for Immuno-Oncology's research into the tumor immune microenvironment, using the GeoMx DSP to perform spatial transcriptomics and proteomics on preclinical and clinical samples. The contract does not have a...
- Nanostring Technologies, Inc. has been awarded a $49,500 purchase order by the National Cancer Institute (NCI), a component of the Department of Health and Human Services' National Institutes of Health (HHS-NIH), to provide an upgrade to geomagnetic data signal processing (GEOMX DSP) software. The firm fixed price contract runs from September 2022 through March 2024 and will be performed in Potomac, Maryland. As the prime contractor, Nanostring will deliver upgraded software to support NCI's...